The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Recent News
GLI Supports the Bipartisan Reintroduction of the Treat and Reduce Obesity Act(Washington, D.C., July 8, 2025) – Global Liver Institute (GLI) applauds the reintroduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the U.S. House of Representatives last...
Treatment Strategies and Advancements in TestingGlobal Liver Institute brings you key updates on emerging treatment strategies and advocacy efforts from global leaders like the World Hepatitis Alliance. In this issue, we offer new resources, a short quiz to see if...
 Global Research and Patient Priorities Emphasizing the Importance of Using Patient-Reported Data at the DIA 2025 Conference, Washington, D.C. Kristin Hatcher, Director of GLI’s Pediatric and Rare Liver Disease Program, joined U.S. and global...
Culturally Relevant Tools to Increase Hepatitis B Screening in Asian American CommunitiesInfection with hepatitis B poses a serious risk to the health of many Americans – especially in certain groups with high risk, including Asian Americans and Asian-American...
Global Liver Institute Leads Efforts in Urging FDA to Recognize Patient-Defined Progress in Drug Development(Washington, D.C. June 24, 2025) – At the Global Liver Institute, we believe that it all starts with a patient because only they define what progress means to...
